{
  "id": 9754147,
  "title": "Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s",
  "url": "https://urgent.news/2026/09/25/novo-is-betting-on-its-next-chapter-as-eli-lilly-gains-more-ground-in",
  "topic": "business",
  "section": "Business",
  "published": "2026-09-25T11:00:01.000Z",
  "source": {
    "name": "CNBC",
    "slug": "cnbc",
    "url": "https://www.cnbc.com/2026/09/25/novo-eli-lilly-obesity-drugs.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the top of the obesity drug market.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Seeking Alpha News",
        "title": "Nektar gains 5% as jury awards $90M plus interest in Lilly trial",
        "url": "https://urgent.news/2026/09/25/nektar-gains-5-as-jury-awards-90m-plus-interest-in-lilly-trial",
        "published": "2026-09-25T11:26:18.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}